Search

everythinglearnresearchcommunity

for

Search:↓

PRP improves hair thickness for both genders, but only increases hair density in men.

WAA-QOL measures impact of hair loss on women's well-being.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Micrografts improve hair density and thickness without side effects.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

PRP shows promise for treating female hair loss but needs more research.

Women with androgenetic alopecia have lower SHBG levels.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Drinking sweetened tea and soda and poor sleep may increase the risk of hair loss in women.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Holistic treatment improved hair growth, reduced hair loss, and boosted well-being.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Male pattern baldness is common and can be managed with early intervention.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Women know more about androgenetic alopecia than men.

Hair loss linked to prostate enlargement; stress and family history important factors.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Women with female pattern hair loss often underestimate how severe it is.

Hair loss link to COVID-19 severity likely due to other factors.

Using both minoxidil and platelet-rich plasma therapy together is more effective for hair growth in women than using minoxidil alone.

Alopecia areata may be linked to heart issues.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.